 |
|
Predictors and clinical outcomes of persistent methicillin-resistant
Hea Sung Ok, Hyoun Soo Lee, Man Je Park, Ki Hoon Kim, Byeong Ki Kim, Yu Mi Wi, June Myung Kim
Korean J Intern Med. 2013;28(6):678-686. Published online 2013 Oct 29 DOI: https://doi.org/10.3904/kjim.2013.28.6.678
|
|
Citations to this article as recorded by
 Inappropriate empirical antibiotic therapy was an independent risk factor of pediatric persistent S. aureus bloodstream infection
Xingmei Wang, Ziyao Guo, Xi Zhang, Guangli Zhang, Qinyuan Li, Xiaoyin Tian, Dapeng Chen, Zhengxiu Luo
European Journal of Pediatrics.2022; 182(2): 719. CrossRef Investigation of biofilm formation in methicillin-resistant Staphylococcus aureus associated with bacteraemia in a tertiary hospital
Wen Kiong Niek, Cindy Shuan Ju Teh, Nuryana Idris, Kwai Lin Thong, Soo Tein Ngoi, Sasheela Sri La Sri Ponnampalavanar
Folia Microbiologica.2021; 66(5): 741. CrossRef Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes
Emi Minejima, Nikki Mai, Nancy Bui, Melissa Mert, Wendy J Mack, Rosemary C She, Paul Nieberg, Brad Spellberg, Annie Wong-Beringer
Clinical Infectious Diseases.2020; 70(4): 566. CrossRef Glycopeptide Hypersensitivity and Adverse Reactions
Vanthida Huang, Nicola A. Clayton, Kimberly H. Welker
Pharmacy.2020; 8(2): 70. CrossRef Methicillin-resistant Staphylococcus aureus bacteraemia, 2003–2015: Comparative evaluation of changing trends in molecular epidemiology and clinical outcomes of infections
Wen Kiong Niek, Cindy Shuan Ju Teh, Nuryana Idris, Pik San Sit, Yee Qing Lee, Kwai Lin Thong, Sasheela Sri La Sri Ponnampalavanar
Infection, Genetics and Evolution.2020; 85: 104567. CrossRef Value of Time to Positivity of Blood Culture in Children with Bloodstream Infections
Fen Pan, Wantong Zhao, Hong Zhang
Canadian Journal of Infectious Diseases and Medical Microbiology.2019; 2019: 1. CrossRef Prognostic Power of Pathogen Cell-Free DNA in Staphylococcus aureus Bacteremia
Alessander O Guimaraes, Johnny Gutierrez, Stacey A Maskarinec, Yi Cao, Kyu Hong, Felicia Ruffin, Montserrat Carrasco-Triguero, Melicent C Peck, Vance G Fowler, Amos Baruch, Carrie M Rosenberger
Open Forum Infectious Diseases.2019;[Epub] CrossRef Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Correlations between clinical, phenotypic, genotypic characteristics and mortality in a tertiary teaching hospital in Malaysia
Pik San Sit, Cindy Shuan Ju Teh, Nuryana Idris, Sasheela Ponnampalavanar
Infection, Genetics and Evolution.2018; 59: 132. CrossRef Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia
Nicolas Cortes-Penfield, Nora T. Oliver, Andrew Hunter, Maria Rodriguez-Barradas
Infectious Diseases.2018; 50(8): 643. CrossRef Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Pedro Ayau, Ana C. Bardossy, Guillermo Sanchez, Ricardo Ortiz, Daniela Moreno, Pamela Hartman, Khulood Rizvi, Tyler C. Prentiss, Mary B. Perri, Meredith Mahan, Vanthida Huang, Katherine Reyes, Marcus J. Zervos
International Journal of Infectious Diseases.2017; 61: 3. CrossRef Septic Thrombophlebitis with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia and de novo Resistance to Vancomycin and Daptomycin
Yael Koton, Zafrir Or, Naiel Bisharat
Infectious Disease Reports.2017; 9(2): 7008. CrossRef The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis
Sasima Tongsai, Pornpan Koomanachai
BMC Research Notes.2016;[Epub] CrossRef Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis
T. Steinmetz, N. Eliakim-Raz, E. Goldberg, L. Leibovici, D. Yahav
Clinical Microbiology and Infection.2015; 21(7): 665. CrossRef Avoiding the Perfect Storm: The Biologic and Clinical Case for Reevaluating the 7-Day Expectation for Methicillin-Resistant Staphylococcus aureus Bacteremia Before Switching Therapy
R. Kullar, J. A. McKinnell, G. Sakoulas
Clinical Infectious Diseases.2014; 59(10): 1455. CrossRef Persistent methicillin-resistantStaphylococcus aureusbacteremia: do we need a new therapeutic strategy?
Cheol-In Kang
The Korean Journal of Internal Medicine.2013; 28(6): 657. CrossRef
|